Evidence-based medicine (EbM) versus health services research: How is complementary oncology represented therein?
Zeitschrift für Phytotherapie(2007)
Abstract
Oncological therapy approaches are measured by hard outcome parameters like survival time, quality of life or at best by the relation of survival time and quality of life (health adjusted life years or quality adjusted life years). Surrogate markers like response under therapy (complete remission, partial remission) or time to progression and laboratory parameters turn out to be invalid therapy aims.
MoreTranslated text
Key words
Health services research,Randomized controlled trials,Oncology Mistletoe,Complementary Medicine
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined